Epithelioid sarcoma: a clinicopathologic review of 55 cases. 1996

A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
Division of Anatomic Pathology, Mayo Clinic Rochester, MN 55905, USA.

OBJECTIVE To identify any clinical and pathologic features of treatment modalities that are predictive of outcome in patients with epithelioid sarcoma, a rare slow-growing soft tissue tumor most commonly occurring in the distal extremities of young adults. METHODS We reviewed the institutional files for cases of epithelioid sarcoma for the period 1956 to 1991 and analyzed the effect of various factors on survival. METHODS Fifty-five cases of epithelioid sarcoma were found, and the relevant clinical, pathologic, treatment, follow-up, and outcome features were assessed. RESULTS All tumors were treated initially by operative resection. The recurrence rate progressively decreased with increasing aggressiveness of the initial operation; however, no difference was noted in metastatic rate. Overall, the recurrence rate was 38% and the metastatic rate was 47%. At the end of a mean follow-up of 102 months, 69% of patients had no evidence of disease, 27% had died of the disease, and 4% were alive with disease. Increasing tumor size, necrosis of more than 30%, and vascular invasion correlated significantly with a worse prognosis. CONCLUSIONS Epithelioid sarcoma should be considered a malignant neoplasm with a significant potential for aggressive behavior, and close follow-up of affected patients should be maintained for many years. Initial treatment should be aggressive in an attempt to prevent recurrence.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008499 Medical Records Recording of pertinent information concerning patient's illness or illnesses. Health Diaries,Medical Transcription,Records, Medical,Transcription, Medical,Diaries, Health,Diary, Health,Health Diary,Medical Record,Medical Transcriptions,Record, Medical,Transcriptions, Medical
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females

Related Publications

A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
April 2009, International journal of surgical pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
July 2016, Zhonghua bing li xue za zhi = Chinese journal of pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
November 1993, Seminars in diagnostic pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
July 2001, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
January 2019, International journal of clinical and experimental pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
April 2021, American journal of clinical pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
January 2011, Zhonghua bing li xue za zhi = Chinese journal of pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
February 2009, American journal of clinical pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
September 2004, The American journal of surgical pathology,
A C Halling, and P C Wollan, and D J Pritchard, and R Vlasak, and A G Nascimento
September 1990, Cancer,
Copied contents to your clipboard!